Literature DB >> 26687160

Insertion/Insertion Genotype of Angiotensin I-Converting-Enzyme Gene Predicts Risk of Myocardial Infarction in North East India.

Sukanya Baruah1, Mriganka S Chaliha2, Prasanta K Borah1, Rashmi Rajkakati2, Prodeep K Borua3, Jagadish Mahanta4.   

Abstract

Myocardial infarction (MI) is common in India and the disease occurs at a relatively younger age. We wanted to look for association of Angiotensin I-converting enzyme (ACE) gene with MI in North East India. We also wanted to examine possible environmental interaction of ACE gene with established cardiovascular risk factors in causation of MI. In the study carried out in Assam Medical College, 200 consecutive confirmed cases of MI were recruited. Equal numbers of age- and sex-matched control subjects from hospital workers and patients attending the hospital for diseases unrelated to cardiovascular disease were enrolled. Structured questionnaires were used to note demographic and clinical factors. Cardiovascular risk factors were determined from history, physical examination and biochemical investigations. ACE insertion/deletion (I/D) polymorphism was determined by PCR method. Interaction of ACE gene with other risk factors was noted. The study identified ACE II genotype (odds ratio = 3.02; 95% CI 1.40-6.51), smoking, hypertension, diabetes and serum triglyceride > 150 mg/dl as independent risk factors for MI. ACE II genotype showed greater risk in non-smokers, non-hypertensives, non-diabetics and in subjects with LDL-C < 130 mg/dl. Low HDL cholesterol enhanced the genetic risk. Subjects with ACE II genotype have an independent risk of developing MI, specially in low cardiovascular risk subjects.

Entities:  

Keywords:  ACE I/D polymorphism; Cardiovascular risk factors; Gene–environment interaction; Myocardial infarction

Mesh:

Substances:

Year:  2015        PMID: 26687160     DOI: 10.1007/s10528-015-9706-9

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  2 in total

Review 1.  The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.

Authors:  Hania K Flaten; Andrew A Monte
Journal:  Cardiovasc Drugs Ther       Date:  2017-08       Impact factor: 3.727

Review 2.  Risk Assessment Using the Association Between Renin-Angiotensin Genes Polymorphisms and Coronary Artery Disease.

Authors:  Mohamed Riad; Prakash Adhikari; Sanket Bhattarai; Ashish Gupta; Eiman Ali; Moeez Ali; Jihan A Mostafa
Journal:  Cureus       Date:  2021-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.